A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation.
HFmrEF
HFpEF
HFrEF
machine learning
secondary tricuspid regurgitation
Journal
European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788
Informations de publication
Date de publication:
24 04 2023
24 04 2023
Historique:
received:
12
10
2022
accepted:
29
12
2022
medline:
26
4
2023
pubmed:
10
2
2023
entrez:
9
2
2023
Statut:
ppublish
Résumé
Secondary tricuspid regurgitation (sTR) is the most frequent valvular heart disease and has a significant impact on mortality. A high burden of comorbidities often worsens the already dismal prognosis of sTR, while tricuspid interventions remain underused and initiated too late. The aim was to examine the most powerful predictors of all-cause mortality in moderate and severe sTR using machine learning techniques and to provide a streamlined approach to risk-stratification using readily available clinical, echocardiographic and laboratory parameters. This large-scale, long-term observational study included 3359 moderate and 1509 severe sTR patients encompassing the entire heart failure spectrum (preserved, mid-range and reduced ejection fraction). A random survival forest was applied to investigate the most important predictors and group patients according to their number of adverse features.The identified predictors and thresholds, that were associated with significantly worse mortality were lower glomerular filtration rate (<60 mL/min/1.73m2), higher NT-proBNP, increased high sensitivity C-reactive protein, serum albumin < 40 g/L and hemoglobin < 13 g/dL. Additionally, grouping patients according to the number of adverse features yielded important prognostic information, as patients with 4 or 5 adverse features had a fourfold risk increase in moderate sTR [4.81(3.56-6.50) HR 95%CI, P < 0.001] and fivefold risk increase in severe sTR [5.33 (3.28-8.66) HR 95%CI, P < 0.001]. This study presents a streamlined, machine learning-derived and internally validated approach to risk-stratification in patients with moderate and severe sTR, that adds important prognostic information to aid clinical-decision-making.
Identifiants
pubmed: 36757905
pii: 7033345
doi: 10.1093/ehjci/jead009
pmc: PMC10125224
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
588-597Subventions
Organisme : Austrian Science Fund
ID : KLI-818B
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: None declared.
Références
Prog Cardiovasc Dis. 2019 Nov - Dec;62(6):463-466
pubmed: 31805294
Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):565-573
pubmed: 30508183
J Am Soc Echocardiogr. 2011 Sep;24(9):1013-9
pubmed: 21820277
ESC Heart Fail. 2021 Oct;8(5):3769-3782
pubmed: 34240828
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Am Coll Cardiol. 2020 Apr 14;75(14):1659-1672
pubmed: 32273031
J Card Fail. 2011 Jun;17(6):451-8
pubmed: 21624732
Circ Cardiovasc Imaging. 2020 May;13(5):e009707
pubmed: 32418453
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Am J Cardiol. 2002 Dec 15;90(12):1405-9
pubmed: 12480058
J Am Coll Cardiol. 2013 Jun 18;61(24):2397-2405
pubmed: 23603231
Circ Cardiovasc Imaging. 2012 May 1;5(3):314-23
pubmed: 22447806
Eur Heart J. 2018 Jan 1;39(1):39-46
pubmed: 29020337
Clin Cardiol. 2019 Mar;42(3):365-372
pubmed: 30637771
Eur Heart J. 2022 Feb 10;43(6):440-441
pubmed: 34922348
Heart. 2019 Dec;105(23):1813-1817
pubmed: 31422359
J Am Heart Assoc. 2018 Jul 13;7(14):
pubmed: 30006492
Eur J Heart Fail. 2012 Jan;14(1):39-44
pubmed: 22158777
Eur Heart J. 2021 Mar 31;42(13):1254-1269
pubmed: 33734354
JACC Cardiovasc Imaging. 2019 Mar;12(3):433-442
pubmed: 30121261
JACC Cardiovasc Interv. 2021 Mar 8;14(5):501-511
pubmed: 33582084
Am Heart J. 2008 May;155(5):883-9
pubmed: 18440336
Eur J Heart Fail. 2019 Jan;21(1):74-85
pubmed: 30328654
J Am Soc Echocardiogr. 2021 Jan;34(1):13-19
pubmed: 33036820
JACC Cardiovasc Imaging. 2020 Sep;13(9):2017-2035
pubmed: 32912474
Circ Res. 2017 Oct 13;121(9):1092-1101
pubmed: 28794054
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1022-1030
pubmed: 28950325
J Am Coll Cardiol. 2021 Aug 10;78(6):545-558
pubmed: 34353531
Eur Heart J Cardiovasc Imaging. 2021 Jul 20;22(8):868-875
pubmed: 33623973
JACC Cardiovasc Imaging. 2021 Dec;14(12):2288-2300
pubmed: 34274262
Eur Heart J. 2013 Mar;34(11):844-52
pubmed: 23335604
Eur Heart J. 2022 Feb 12;43(7):654-662
pubmed: 34586392
JACC Cardiovasc Imaging. 2019 Mar;12(3):389-397
pubmed: 30660536
Ann Thorac Surg. 2013 Nov;96(5):1546-52; discussion 1552
pubmed: 24070702
J Am Coll Cardiol. 2021 Jan 26;77(3):229-239
pubmed: 33478646
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116